Their study showed strong evidence that PDE5 inhibitor users are more likely to have solar keratosis before PDE5 inhibitors prescription, which proposed the possibility that those PDE5 inhibitor users might had experienced excess sun exposure and it is more likely to develop melanoma. Here, PDE5A is linked to actinic keratosis.